Fluicell AB (FLUI) - Cash Flow Conversion Efficiency

Latest as of September 2025: -0.114x

Based on the latest financial reports, Fluicell AB (FLUI) has a cash flow conversion efficiency ratio of -0.114x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Skr-1.23 Million ≈ $-132.37K USD) by net assets (Skr10.80 Million ≈ $1.16 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Fluicell AB - Cash Flow Conversion Efficiency Trend (2016–2024)

This chart illustrates how Fluicell AB's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read Fluicell AB balance sheet liabilities for a breakdown of total debt and financial obligations.

Fluicell AB Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Fluicell AB ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
International Prospect Ventures Ltd V:IZZ	-0.357x
Martello Technologies Group Inc V:MTLO	0.035x
Downing Renewables & Infrastructure Trust PLC LSE:DORE	0.022x
Human Xtensions Ltd TA:HUMX	-2.866x
CPT GLOBAL LTD F:714	N/A
Luxbright AB ST:LXB	-0.321x
CCSC Technology International Holdings Limited Ordinary Shares NASDAQ:CCTG	-0.004x
Propanc Biopharma, Inc. Common Stock NASDAQ:PPCB	-0.096x

Annual Cash Flow Conversion Efficiency for Fluicell AB (2016–2024)

The table below shows the annual cash flow conversion efficiency of Fluicell AB from 2016 to 2024. For the full company profile with market capitalisation and key ratios, see how much is Fluicell AB worth.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	Skr19.23 Million ≈ $2.07 Million	Skr-15.67 Million ≈ $-1.69 Million	-0.815x	+98.73%
2023-12-31	Skr425.00K ≈ $45.74K	Skr-27.23 Million ≈ $-2.93 Million	-64.064x	-7037.92%
2022-12-31	Skr23.45 Million ≈ $2.52 Million	Skr-21.04 Million ≈ $-2.26 Million	-0.898x	+7.98%
2021-12-31	Skr19.11 Million ≈ $2.06 Million	Skr-18.64 Million ≈ $-2.01 Million	-0.975x	-8.24%
2020-12-31	Skr19.50 Million ≈ $2.10 Million	Skr-17.57 Million ≈ $-1.89 Million	-0.901x	+46.02%
2019-12-31	Skr10.22 Million ≈ $1.10 Million	Skr-17.07 Million ≈ $-1.84 Million	-1.669x	-213.09%
2018-12-31	Skr23.37 Million ≈ $2.52 Million	Skr-12.46 Million ≈ $-1.34 Million	-0.533x	+34.76%
2017-12-31	Skr9.58 Million ≈ $1.03 Million	Skr-7.83 Million ≈ $-842.74K	-0.817x	+72.63%
2016-12-31	Skr1.84 Million ≈ $198.12K	Skr-5.50 Million ≈ $-591.56K	-2.986x	--

About Fluicell AB

ST:FLUI Sweden Biotechnology

Market Cap

$2.11 Million

Skr19.58 Million SEK

Market Cap Rank

#29637 Global

#688 in Sweden

Share Price

Skr14.25

Change (1 day)

+6.34%

52-Week Range

Skr7.70 - Skr21.00

All Time High

Skr188.78